Category Archives: Specialty Drug

Genetic Testing Privacy Concerns Increasing

Genetic testing companies are forming a new coalition on best practices for handling DNA information and to promote the industry in Washington as lawmakers put more scrutiny on their privacy practices. Three companies — Ancestry, 23andMe and Helix, which provide DNA testing and analysis — formed the Coalition for Genetic Data Protection. The move comes […]

EVERSANA Adds to its Comprehensive Platform of Life Sciences Services

Water Street Healthcare Partners and JLL Partners joined forces to acquire and combine one of the most comprehensive platform of life sciences services in the industry. The new companies EVERSANA offers more than 500 clients the services they need to bring critical therapies to market while improving the lives of patients around the world. EVERSANA […]

The specialty pharmaceutical hub market continues to evolve entering 2019 with new entrants, investment, and consolidation

Specialty Pharmaceutical Hub Services Providers 2019 Report

Employers Use of Copay Accumulator Programs is Growing

man looking at virtual customers

Walmart and Home Depot, two of the top 10 U.S. employers, are using copay accumulator programs

Specialty Pharmacy Market Overview – Market Shakeout Continuing into 2018

Specialty Pharmacy Market Overview – Market Shakeout Continuing into 2018 As the specialty drug spend grows, specialty pharmacies are playing an increasingly larger role in access and delivery of medications and services. The specialty pharmacy market, while dominated by a few large companies, has an increasing number of participants. AMI’s annual report, Specialty Pharmacy Market […]

Amber Specialty Pharmacy Leads Patient Satisfaction

Amber Specialty Pharmacy leads patient satisfaction. Amber Pharmacy, a wholly owned subsidiary of Hy-Vee, is the No. 1 ranked specialty pharmacy in the U.S. for patient satisfaction with pharmacy employees, according to a recent Zitter Health Insights survey. The survey assessed numerous aspects of patient satisfaction and garnered responses from more than 3,000 patients across 38 […]

Employer Perspectives Specialty Drug Step-Therapy Program Evaluation

Employer Perspectives Specialty Drug Step-Therapy Program Evaluation American Health and Drug Benefits, September 2016 Vol 9, No 6 – Industry Trends Matthew Harman, PharmD, MPH, Director, Clinical Pharmacy Strategies Employers Health, Columbus, OH F. Randy Vogenberg, PhD, RPh, Strategic Advisor and Co–Project Leader, Midwest Business Group on Health National Employer Biologics & Specialty Drug Initiative […]